Hologic expects to grant to the underwriters an option to purchase up to an additional $195 million aggregate principal amount of notes to cover over-allotments. Goldman, Sachs & Co. is acting as sole book-running manager of the offering.
The company intends to use the net proceeds from the offering to repay a portion of its outstanding senior secured indebtedness.